Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112992 · ClinicalTrials.gov registry record
An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects
A clinical trial of Bone Loss and Limb Fracture, sponsored by AO Innovation Translation Center.
- Recruiting
- Registry status
- 600
- Enrollment target
- 20
- Study locations
NCT04112992 is a study of Bone Loss and Limb Fracture that is actively recruiting participants, run by AO Innovation Translation Center. The registered enrollment target is 600 participants, above the 217-participant average among 16 other Bone Loss trials with a reported enrollment target (176% higher). The trial reports 20 study locations across 3 states.
The verdict
NCT04112992, a study of Bone Loss and Limb Fracture, is actively recruiting participants, sponsored by AO Innovation Translation Center.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 20
- Study locations
Study Summary
Long bone defect (LBD) is defined as a focalized loss of bone tissue in any long bone of the upper or lower extremity. Long bone defects are a complex problem, that may arise as a complication of many different pathologies, such as trauma, tumors or infection. Whereas post-traumatic defects are the largest group. Reports estimate that there are almost 4 million bone grafting procedures worldwide per year. However, limb reconstruction in the context of a bony defect is challenging and up to date there is little evidence and treatment recommendations. In a multi-national approach, the aim of this project is to set up an international, multicenter registry to gather information and details on prevalence or incidence, current treatments, complications and outcome.
Conditions Studied
Interventions
- PROCEDURE Any treatment that is used for a defect of any long bone
Study Locations (20)
Other
- John Hunter Hospital - Newcastle
- Hospital Municipal Miguel Couto Serviço de Ortopedia e Traumatologia - Rio de Janeiro
- Hospital Base Valdivia - Valdivia
- Hospital Universitario de la Samaritana - Bogotá
- Hospital Pablo Tobon Uribe - Medellín
- University Hospital Frankfurt - Frankfurt
- Universitätsspital Gießen - Giessen
- Universitätsklinikum Heidelberg (Unfallchirurgie) - Heidelberg
- Universitätsklinikum Münster (Klinik und Poliklinik für Unfall-, Hand- und Wiederherstellungschirurgie) - Münster
- Krankenhaus Johanneum - Wildeshausen
- Paras HMRI Hospital Patna - Patna
- Academisch Ziekenhuis Maastricht (Dept. of Surgery) - Maastricht
- Radboud University Medical Center - Nijmegen
- Tygerberg Hospital - Cape Town
- Kyungpook National University Hospital (Orthopaedics) - Daegu
- Universitätsspital Zürich (Klinik für Traumatologie) - Zurich
- Central Hospital of Border Guard Service of Ukraine - Kyiv
- Leeds General Infirmary University Hospital (Trauma & Orthopaedic Surgery) - Leeds
California
- Cedar Sinai - Los Angeles
Maryland
- Sinai Hospital of Baltimore - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-07-03 |
| Est. Completion | 2029-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04112992
The ClinicalTrials.gov registry entry for NCT04112992 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 217-participant average among 16 other Bone Loss trials with a reported enrollment target (176% higher). The listed sponsor is AO Innovation Translation Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bone Loss appearing as the primary indexed condition, and to 1 intervention - of which Any treatment that is used for a defect of any long bone is the first listed.
NCT04112992 reports 20 study locations spanning 3 distinct geographic areas - top geographies include Other, California, Maryland.
Frequently Asked Questions
What is clinical trial NCT04112992 about?
NCT04112992 is a clinical study titled "An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects". Long bone defect (LBD) is defined as a focalized loss of bone tissue in any long bone of the upper or lower extremity. Long bone defects are a complex problem, that may arise as a complication of many different pathologies, such as trauma, tumors or infection. Whereas post-traumatic defects are the ...
What is the current status of trial NCT04112992?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2024-07-03. Estimated completion is 2029-03-30.
What conditions does trial NCT04112992 study?
This clinical trial studies the following conditions: Bone Loss, Limb Fracture.
What interventions are being tested in trial NCT04112992?
The interventions under investigation include: Any treatment that is used for a defect of any long bone (PROCEDURE).
Who is sponsoring clinical trial NCT04112992?
This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04112992 being conducted?
This trial has 20 study locations across California, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bone, Exercise, Alendronate, and Caloric Restriction
RECRUITING · Phase 4
-
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
RECRUITING
-
Bone in CKD Alkali Response (BICARb Pilot Trial)
RECRUITING · Phase 2
-
Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth Factor
RECRUITING · NA
-
Lutein, Zeaxathin, and Fish Oil Supplementation
RECRUITING · NA
-
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.